Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Antikörper:
anti-Rat (Rattus) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal PGF Primary Antibody für IHC, ELISA - ABIN1585069
Bagley, Ren, Weber, Yao, Kurtzberg, Pinckney, Bangari, Nguyen, Brondyk, Kaplan, Teicher: Placental growth factor upregulation is a host response to antiangiogenic therapy. in Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Show all 3 Pubmed References
Mouse (Murine) Polyclonal PGF Primary Antibody für IF (p), IHC (p) - ABIN727220
Zhang, Zhao, Yuan, Wu, Jiang, Luo: Placenta growth factor contributes to cell apoptosis and epithelial-to-mesenchymal transition in the hyperoxia-induced acute lung injury. in Life sciences 2016
Show all 2 Pubmed References
Human Polyclonal PGF Primary Antibody für ELISA, ICC - ABIN269292
Janér, Andersson, Haglund, Karikoski, Lassus: Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development. in Pediatrics 2008
Human Polyclonal PGF Primary Antibody für ELISA, WB - ABIN4238908
Cao, Ji, Qi, Rosin, Cao: Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. in Biochemical and biophysical research communications 1997
Results show that both FLT1 (zeige FLT1 Antikörper) and PGF are overexpressed in the circulating tumor cells (CTCs) of patients with breast cancer. Also, a functional interaction of sFlt1 (zeige FLT1 Antikörper) and PGF was found, suggesting that their overexpression in tumor cells inhibits CTCs entering the peripheral blood.
Identify a novel cis (zeige CISH Antikörper)-acting sequence (-369 to -320) at the placental growth factor promoter, which was critical for mediating the basal and DLX3 (zeige DLX3 Antikörper)/GCM1 (zeige GCM1 Antikörper)-dependent PGF promoter activities.
Low PlGF identifies small fetuses with significant underlying placental pathology and is a promising tool for antenatal discrimination of fetal growth retardation from fetuses who are constitutionally-small.
Serum and urinary sFlt-1 and sFlt-1/PLGF ratios in severe preeclampsia patients were significantly higher than those in the mild preeclampsia group, and mild preeclampsia patients were significantly higher than controls. The serum and urinary PLGF levels in severe preeclampsia patients were significantly lower than mild preeclampsia patients, and mild preeclampsia patients had significantly lower PLGF levels than controls
ROS (zeige ROS1 Antikörper) activation of the MAPK (ERK (zeige MAPK1 Antikörper)-1 (zeige MAPK3 Antikörper)/2)/Egr-1 (zeige EGR1 Antikörper) pathway is a main player in the regulatory mechanism for cigarette smoke extract-induced PlGF production. Antioxidants could partly abolish these effects.
Both the TNF-alpha (zeige TNF Antikörper)/IL-10 (zeige IL10 Antikörper) and sFlt-1/PlGF ratios were higher in placental homogenate of early-onset Preeclampsia (PE) than late-onset PE and control groups. The more severe lesions and the imbalance between TNF-alpha (zeige TNF Antikörper)/IL-10 (zeige IL10 Antikörper) and PlGF/sFlt-1 in placentas from early-onset PE allows differentiation of early and late-onset PE and suggests higher placental impairment in early-onset PE
PlGF is abundant in the human endometrium, and secreted into the uterine lumen where it mediates functional changes in cellular adhesion with important roles in implantation
The preeclampsia group had lower placental growth factor from 18 weeks compared to controls.
A strong, novel prospective association was identified between lower concentrations of soluble Fms (zeige CSF1R Antikörper)-like kinase 1 and placental growth factor measured in early pregnancy and spontaneous abortion.
Women with preeclampsia had lower plasma concentrations of placental growth factor. The uteroplacental arteriovenous differences of placental growth factor were significant in both preeclampsia and control groups.
PGF (zeige PTGFR Antikörper) deficiency is associated with impaired cerebral vascular development in mice.
PlGF inhibition attenuates PERK (zeige EIF2AK3 Antikörper) activation, likely by tempering hypoxia in HCC (zeige FAM126A Antikörper) via vessel normalisation. The UPR is able to regulate PlGF expression, suggesting the existence of a feedback mechanism for hypoxia-mediated UPR
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 (zeige IL13 Antikörper).
Data indicate that placental growth factor (PlGF) is needed in the spleen to allow the activation of T cells and blood pressure raising.
Placental growth factor promotes differentiation of bone marrow-derived macrophages and enhanced vascular endothelial cell proliferation.
PLGF in LC cells induced macrophage polarization in vivo, and significantly promoted the growth of LC.
PLGF is upregulated in vascular cells in response to fluid shear stress.
Data suggests that PLGF may target islet endothelia to release growth factors activating PI3k signalling in beta cells to increase their proliferation. In Pre-Eclampsia, PLGF reduction impairs these processes resulting in gestational diabetes mellitus.
The neutrophil elastase (zeige ELANE Antikörper)-PlGF-JNK (zeige MAPK8 Antikörper)/PKCdelta (zeige PKCd Antikörper) pathway contributes to the pathogenesis of lung epithelial cell apoptosis and emphysema.
E2F1 (zeige E2F1 Antikörper) limits cardiac neovascularization and functional recovery after myocardial infarction by suppressing VEGF (zeige VEGFA Antikörper) and PlGF up-regulation through p53 (zeige TP53 Antikörper)-dependent and -independent mechanisms, respectively.
Study reports polymorphisms in the bovine PGF gene significantly associated with the maternal effect (zeige NLRP5 Antikörper) on stillbirth and calving ease in animals under selection.
placenta growth factor expression is regulated by both VEGF (zeige VEGFA Antikörper) and hyperglycaemia via VEGFR-2 (zeige KDR Antikörper)
This gene encodes a growth factor found in placenta which is homologous to vascular endothelial growth factor. Alternatively spliced transcripts encoding different isoforms have been found for this gene.
placental growth factor, vascular endothelial growth factor-related protein
, placenta growth factor
, placenta growth factor-like